Saturday, 25 December 2010

Predniocil




Predniocil may be available in the countries listed below.


Ingredient matches for Predniocil



Prednisolone

Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Predniocil in the following countries:


  • Portugal

International Drug Name Search

Thursday, 23 December 2010

Arluy




Arluy may be available in the countries listed below.


Ingredient matches for Arluy



Mebeverine

Mebeverine is reported as an ingredient of Arluy in the following countries:


  • Mexico

International Drug Name Search

Wednesday, 22 December 2010

Ramitalate L




Ramitalate L may be available in the countries listed below.


Ingredient matches for Ramitalate L



Nifedipine

Nifedipine is reported as an ingredient of Ramitalate L in the following countries:


  • Japan

International Drug Name Search

Monday, 20 December 2010

Tantum Activ Gola




Tantum Activ Gola may be available in the countries listed below.


Ingredient matches for Tantum Activ Gola



Flurbiprofen

Flurbiprofen is reported as an ingredient of Tantum Activ Gola in the following countries:


  • Italy

International Drug Name Search

Thursday, 16 December 2010

Wycillina




Wycillina may be available in the countries listed below.


Ingredient matches for Wycillina



Benzylpenicillin

Benzylpenicillin benzathine (a derivative of Benzylpenicillin) is reported as an ingredient of Wycillina in the following countries:


  • Italy

International Drug Name Search

Wednesday, 15 December 2010

Vibrocil Microdosificador




Vibrocil Microdosificador may be available in the countries listed below.


Ingredient matches for Vibrocil Microdosificador



Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Vibrocil Microdosificador in the following countries:


  • Peru

International Drug Name Search

Monday, 13 December 2010

Clofozine




Clofozine may be available in the countries listed below.


Ingredient matches for Clofozine



Clofazimine

Clofazimine is reported as an ingredient of Clofozine in the following countries:


  • India

International Drug Name Search

Saturday, 11 December 2010

Fragmine




Fragmine may be available in the countries listed below.


Ingredient matches for Fragmine



Dalteparin

Dalteparin Sodium is reported as an ingredient of Fragmine in the following countries:


  • France

  • Tunisia

International Drug Name Search

Thursday, 9 December 2010

Irinotecan Rontag




Irinotecan Rontag may be available in the countries listed below.


Ingredient matches for Irinotecan Rontag



Irinotecan

Irinotecan is reported as an ingredient of Irinotecan Rontag in the following countries:


  • Argentina

International Drug Name Search

Monday, 6 December 2010

Minalfene




Minalfene may be available in the countries listed below.


Ingredient matches for Minalfene



Alminoprofen

Alminoprofen is reported as an ingredient of Minalfene in the following countries:


  • Taiwan

International Drug Name Search

Friday, 3 December 2010

Prolert




Prolert may be available in the countries listed below.


Ingredient matches for Prolert



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Prolert in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, 1 December 2010

Rispone




Rispone may be available in the countries listed below.


Ingredient matches for Rispone



Risperidone

Risperidone is reported as an ingredient of Rispone in the following countries:


  • Ireland

International Drug Name Search

Wednesday, 24 November 2010

Wemid




Wemid may be available in the countries listed below.


Ingredient matches for Wemid



Erythromycin

Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Wemid in the following countries:


  • Argentina

International Drug Name Search

Sunday, 21 November 2010

Regivell




Regivell may be available in the countries listed below.


Ingredient matches for Regivell



Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Regivell in the following countries:


  • Indonesia

International Drug Name Search

Vellutan




Vellutan may be available in the countries listed below.


Ingredient matches for Vellutan



Tacalcitol

Tacalcitol monohydrate (a derivative of Tacalcitol) is reported as an ingredient of Vellutan in the following countries:


  • Italy

International Drug Name Search

Saturday, 20 November 2010

Boucren




Boucren may be available in the countries listed below.


Ingredient matches for Boucren



Cetrimide

Cetrimide is reported as an ingredient of Boucren in the following countries:


  • Argentina

International Drug Name Search

Friday, 19 November 2010

Ponstan




Ponstan may be available in the countries listed below.


UK matches:

  • Ponstan Capsules 250mg (SPC)
  • Ponstan Forte Tablets 500mg (SPC)

Ingredient matches for Ponstan



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Ponstan in the following countries:


  • Australia

  • Belize

  • Brazil

  • Colombia

  • Costa Rica

  • Ecuador

  • El Salvador

  • Finland

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • India

  • Indonesia

  • Ireland

  • Mexico

  • Myanmar

  • New Zealand

  • Nicaragua

  • Oman

  • Panama

  • Peru

  • Philippines

  • Portugal

  • Singapore

  • Sri Lanka

  • Switzerland

  • Taiwan

  • Thailand

  • Turkey

  • United Kingdom

  • Venezuela

  • Vietnam

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 14 November 2010

Karbamazepin




Karbamazepin may be available in the countries listed below.


Ingredient matches for Karbamazepin



Carbamazepine

Carbamazepine is reported as an ingredient of Karbamazepin in the following countries:


  • Norway

International Drug Name Search

Saturday, 13 November 2010

Vetacide




Vetacide may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetacide



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Vetacide in the following countries:


  • New Zealand

International Drug Name Search

Tuesday, 9 November 2010

Sakavir




Sakavir may be available in the countries listed below.


Ingredient matches for Sakavir



Saquinavir

Saquinavir is reported as an ingredient of Sakavir in the following countries:


  • Colombia

  • Peru

International Drug Name Search

Sunday, 7 November 2010

Butil




Butil may be available in the countries listed below.


Ingredient matches for Butil



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Butil in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 3 November 2010

Pondera




Pondera may be available in the countries listed below.


Ingredient matches for Pondera



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Pondera in the following countries:


  • Brazil

International Drug Name Search

Tuesday, 26 October 2010

Hanalgeze




Hanalgeze may be available in the countries listed below.


Ingredient matches for Hanalgeze



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Hanalgeze in the following countries:


  • Peru

International Drug Name Search

Thursday, 21 October 2010

Beta-Val Cream


Pronunciation: bay-ta-METH-a-sone VAL-eh-rate
Generic Name: Betamethasone Valerate
Brand Name: Beta-Val


Beta-Val Cream is used for:

Reducing itching, redness, and swelling associated with many skin conditions.


Beta-Val Cream is a topical corticosteroid. It works by depressing the formation, release, and activity of different cells and chemicals that cause swelling, redness, and itching.


Do NOT use Beta-Val Cream if:


  • you are allergic to any ingredient in Beta-Val Cream

Contact your doctor or health care provider right away if any of these apply to you.



Before using Beta-Val Cream:


Some medical conditions may interact with Beta-Val Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have thinning of the skin, a skin infection, tuberculosis (TB), chickenpox, shingles, measles, or a positive TB skin test, or have recently been vaccinated

Some MEDICINES MAY INTERACT with Beta-Val Cream. Because little, if any, of Beta-Val Cream is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Beta-Val Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Beta-Val Cream:


Use Beta-Val Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Do not mix Beta-Val Cream with other medications.

  • Apply a small amount of medicine to the affected area. Gently rub the medicine in until it is evenly distributed. Wash your hands after applying Beta-Val Cream, unless your hands are part of the treated area.

  • Do not cover the areas being treated with bandages or other dressings unless advised to do so by your doctor.

  • If you miss a dose of Beta-Val Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Beta-Val Cream.



Important safety information:


  • Avoid long-term use, especially near the eyes, on the face, on the genital and rectal areas, and in skin folds.

  • Beta-Val Cream is for external use only. Avoid contact with eyes or eyelids. If you get Beta-Val Cream in your eyes, immediately flush with cool tap water.

  • Do not use Beta-Val Cream for other skin conditions at a later time.

  • If Beta-Val Cream was prescribed to treat the diaper area of a child, avoid using tight-fitting diapers or plastic pants.

  • Beta-Val Cream should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Beta-Val Cream while you are pregnant. It is not known if Beta-Val Cream is found in breast milk. If you are or will be breast-feeding while you use Beta-Val Cream, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Beta-Val Cream:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Acne; cracking and stinging of the skin; dryness; excessive hair growth; inflamed hair follicles; itching; skin irritation.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); itching, burning, redness, or swelling not present before the use of Beta-Val Cream; secondary infection; skin thinning and discoloration.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Beta-Val side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center ( http://www.aapcc.org), or emergency room immediately. Beta-Val Cream may be harmful if swallowed.


Proper storage of Beta-Val Cream:

Store Beta-Val Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Beta-Val Cream out of the reach of children and away from pets.


General information:


  • If you have any questions about Beta-Val Cream, please talk with your doctor, pharmacist, or other health care provider.

  • Beta-Val Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Beta-Val Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Beta-Val resources


  • Beta-Val Side Effects (in more detail)
  • Beta-Val Use in Pregnancy & Breastfeeding
  • Beta-Val Drug Interactions
  • Beta-Val Support Group
  • 0 Reviews for Beta-Val - Add your own review/rating


Compare Beta-Val with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Dermatological Disorders
  • Lichen Planus
  • Lichen Sclerosus

Sunday, 17 October 2010

Cétirizine Sandoz




Cétirizine Sandoz may be available in the countries listed below.


Ingredient matches for Cétirizine Sandoz



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cétirizine Sandoz in the following countries:


  • France

International Drug Name Search

Monday, 11 October 2010

Metohexal retard




Metohexal retard may be available in the countries listed below.


Ingredient matches for Metohexal retard



Metoprolol

Metoprolol succinate (a derivative of Metoprolol) is reported as an ingredient of Metohexal retard in the following countries:


  • Austria

International Drug Name Search

Moxaverine Hydrochloride




Moxaverine Hydrochloride may be available in the countries listed below.


Ingredient matches for Moxaverine Hydrochloride



Moxaverine

Moxaverine Hydrochloride (BANM) is also known as Moxaverine (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 8 October 2010

Norsulin




Norsulin may be available in the countries listed below.


Ingredient matches for Norsulin



Gliclazide

Gliclazide is reported as an ingredient of Norsulin in the following countries:


  • Poland

International Drug Name Search

Thursday, 7 October 2010

Vinorelbine




In the US, Vinorelbine (vinorelbine systemic) is a member of the drug class mitotic inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

  • Vinorelbine

  • Vinorelbine Intravenous

  • Vinorelbine Tartrate

UK matches:

  • Vinorelbine 10mg/ml concentrate for solution for infusion (Actavis UK Ltd)
  • Vinorelbine 10 mg/ml Concentrate for solution for infusion (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01CA04

CAS registry number (Chemical Abstracts Service)

0071486-22-1

Chemical Formula

C45-H54-N4-O8

Molecular Weight

778

Therapeutic Category

Antineoplastic agent, microtubule inhibitor

Chemical Name

3',4'-Didehydro-4'-deoxy-8'-norvincaleukoblastine

Foreign Names

  • Vinorelbinum (Latin)
  • Vinorelbin (German)
  • Vinorelbine (French)
  • Vinorelbina (Spanish)

Generic Names

  • Vinorelbine (OS: DCF, BAN)
  • 5'-Noranhydrovinblastine (IS)
  • KW 2307 (IS)
  • Vinorelbine (PH: USP 28)
  • Vinorelbine Tartrate (OS: BANM, USAN)
  • Didehydrodeoxynorvincaleukoblastine (IS)
  • Vinorelbin bitartrate (IS)
  • Vinorelbine Tartrate (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Vinorelbini tartras (PH: Ph. Eur. 6)

Brand Names

  • Eunexon
    AC Farma, Peru


  • Maverex
    Verofarm, Russian Federation


  • Navelbine
    PF, Luxembourg; Pierre Fabre, Germany; Pierre Fabre, Denmark; Pierre Fabre, Spain; Pierre Fabre, Israel; Pierre Fabre, Poland; Pierre Fabre, Romania; Pierre Fabre, Singapore; Pierre Fabre, Tunisia; Pierre Fabre, Turkey; Pierre Fabre Medicament, Slovenia


  • Navirel
    Medac, Czech Republic; Medac, Germany


  • Tevarelbine
    Pharmachemie, Bulgaria


  • Vilbine
    Richmond, Peru


  • Vilne
    Dosa, Argentina


  • Vinelbine
    Dabur, Georgia


  • Vinorayne
    Hospira, Poland


  • Vinorelbin Hexal
    Hexal, Germany


  • Vinorelbin Hospira
    Hospira, Hungary


  • Vinorelbin Sindan
    Sindan, Romania


  • Vinorelbina Ferrer Farma
    Ferrer, Spain


  • Vinorelbina Sandoz
    Sandoz, Colombia


  • Vinorelbina
    Biocrom, Peru


  • Vinorelbine Biocrom
    Biocrom, Argentina


  • Bagovir
    Armstrong, Mexico


  • Bendarelbin
    Bendalis, Germany


  • Eberelbin
    Ebewe, Austria


  • Filcrin
    Filaxis, Argentina


  • Min Nuo Bin
    Minsheng, China


  • Navelbin
    Pierre Fabre, Hungary


  • Navelbine
    Baxter, Chile; Baxter, Philippines; Boehringer Ingelheim, Austria; GlaxoSmithKline, Guyana; Kyowa Hakko Kirin, Japan; Orient Europharma, Taiwan; Pierre Fabre, Argentina; Pierre Fabre, Australia; Pierre Fabre, Belgium; Pierre Fabre, Canada; Pierre Fabre, China; Pierre Fabre, Czech Republic; Pierre Fabre, Germany; Pierre Fabre, Denmark; Pierre Fabre, Estonia; Pierre Fabre, Finland; Pierre Fabre, United Kingdom; Pierre Fabre, Georgia; Pierre Fabre, Greece; Pierre Fabre, Iceland; Pierre Fabre, Italy; Pierre Fabre, Lithuania; Pierre Fabre, Latvia; Pierre Fabre, Malta; Pierre Fabre, Netherlands; Pierre Fabre, Norway; Pierre Fabre, Oman; Pierre Fabre, Poland; Pierre Fabre, Romania; Pierre Fabre, Russian Federation; Pierre Fabre, Sweden; Pierre Fabre, United States; Pierre Fabre, Vietnam; Pierre Fabre Medicament, Slovakia; Pierre Fabre Médicament, France; Pierre-Fabre, Mexico; Robapharm, Switzerland; Tema Medical, South Africa; Transfarma Medica Indah, Indonesia


  • Navildez
    Cryopharma, Mexico


  • Navin
    Cancernova, Germany


  • Navirel
    Medac, Denmark; Medac, Finland; Medac, Netherlands; Medac, Norway; Medac, Poland; Medac, Sweden; Medac, Slovakia


  • Neocitec
    Novartis, Brazil; Sandoz, Argentina


  • Nibrevin
    Ingers, Czech Republic


  • Norelbin
    Eurofarma, Brazil


  • Riborelbin
    Ribosepharm, Germany


  • Sulcoline
    Teva, Argentina


  • Vinarine
    LKM, Argentina


  • Vinelbine
    Dabur, India; Dabur, Myanmar


  • Vinorelbin Actavis
    Actavis, Sweden


  • Vinorelbin Caduceus
    Caduceus Pharma, Slovakia


  • Vinorelbin cell pharm
    Cell pharm, Germany


  • Vinorelbin DRAC
    Dermapharm, Switzerland


  • Vinorelbin Ebewe
    Alliance, Poland; Ebewe, Czech Republic; Ebewe, Estonia; Ebewe, Hungary; Ebewe, Lithuania; Ebewe, Latvia; Ebewe, Slovenia; Ebewe Pharma, Denmark; Ebewe Pharma, Slovakia; Meda, Sweden; Sandoz, Switzerland


  • Vinorelbin Hospira
    Hospira Nordic, Sweden


  • Vinorelbin Mayne
    Hospira, Norway


  • Vinorelbin Medac
    Medac, Austria; Medac, Hungary


  • Vinorelbin NC
    NeoCorp, Germany


  • Vinorelbin Sandoz
    Sandoz, Austria; Sandoz, Slovakia


  • Vinorelbina Varifarma
    Varifarma, Argentina


  • Vinorelbina
    Kampar, Chile


  • Vinorelbin-Actavis
    Actavis, Austria; Actavis, Switzerland; Actavis, Germany


  • Vinorelbine ActavisGroup
    Actavis Group, Netherlands


  • Vinorelbine All-Gen
    All-Gen, Netherlands


  • Vinorelbine Ebewe
    Ebewe, France; Ebewe, Netherlands; InterPharma, New Zealand


  • Vinorelbine Hospira
    Hospira, Netherlands


  • Vinorelbine Mayne
    Faulding, France


  • Vinorelbine PCH
    Pharmachemie, Netherlands


  • Vinorelbine Sandoz
    Sandoz, Netherlands


  • Vinorelbine Tartrate
    Actavis, United States; APP, United States; Baxter, United States; Bedford, United States; Ebewe, United States; Hospira, Canada; Hospira, United States; Mayne, United States; Novopharm, Canada; Sicor, United States; Teva USA, United States


  • Vinorelbine Teva
    Teva, Latvia; Teva Santé, France


  • Vinorelbine
    Delta Farma, Argentina; Hospira, Australia; Mayne, Hong Kong; Medac, United Kingdom


  • Vinorgen
    Bioprofarma, Argentina


  • Vinotel
    Dabur, Philippines

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Ondeton




Ondeton may be available in the countries listed below.


Ingredient matches for Ondeton



Ondansetron

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondeton in the following countries:


  • Greece

International Drug Name Search

Dextropirine




Dextropirine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dextropirine



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Dextropirine in the following countries:


  • France

International Drug Name Search

Tuesday, 5 October 2010

Carncide




Carncide may be available in the countries listed below.


Ingredient matches for Carncide



Diethylcarbamazine

Diethylcarbamazine is reported as an ingredient of Carncide in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 4 October 2010

Effizinc




Effizinc may be available in the countries listed below.


Ingredient matches for Effizinc



Zinc Gluconate

Zinc Gluconate is reported as an ingredient of Effizinc in the following countries:


  • France

  • Luxembourg

International Drug Name Search

Saturday, 2 October 2010

Verum




Verum may be available in the countries listed below.


Ingredient matches for Verum



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Verum in the following countries:


  • Colombia

International Drug Name Search

Thursday, 30 September 2010

E.S.E.




E.S.E. may be available in the countries listed below.


Ingredient matches for E.S.E.



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of E.S.E. in the following countries:


  • Portugal

International Drug Name Search

Monday, 27 September 2010

Colchiquim




Colchiquim may be available in the countries listed below.


Ingredient matches for Colchiquim



Colchicine

Colchicine is reported as an ingredient of Colchiquim in the following countries:


  • Mexico

International Drug Name Search

Friday, 24 September 2010

Oxilan




In the US, Oxilan (ioxilan systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Aortography, Body Imaging, Cerebral Arteriography, Coronary Arteriography, Head Imaging, Intravenous Urography, Left Ventriculography, Peripheral Arteriography and Visceral Arteriography.

US matches:

  • Oxilan

Ingredient matches for Oxilan



Ioxilan

Ioxilan is reported as an ingredient of Oxilan in the following countries:


  • Turkey

  • United States

International Drug Name Search

Thursday, 23 September 2010

Ornidazol-Vero




Ornidazol-Vero may be available in the countries listed below.


Ingredient matches for Ornidazol-Vero



Ornidazole

Ornidazole is reported as an ingredient of Ornidazol-Vero in the following countries:


  • Russian Federation

International Drug Name Search

Wednesday, 22 September 2010

Omeprazol Katwijk




Omeprazol Katwijk may be available in the countries listed below.


Ingredient matches for Omeprazol Katwijk



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Katwijk in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 19 September 2010

Tetracyklin Dak




Tetracyklin Dak may be available in the countries listed below.


Ingredient matches for Tetracyklin Dak



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tetracyklin Dak in the following countries:


  • Denmark

International Drug Name Search

Friday, 17 September 2010

Vinpocetine




In the US, Vinpocetine (vinpocetine systemic).

US matches:

  • Vinpocetine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06BX18

CAS registry number (Chemical Abstracts Service)

0042971-09-5

Chemical Formula

C22-H26-N2-O2

Molecular Weight

350

Therapeutic Category

Vasodilator, cerebral

Chemical Name

Eburnamenine-14-carboxylic acid, ethyl ester, (3α,16α)-

Foreign Names

  • Vinpocetinum (Latin)
  • Vinpocetin (German)
  • Vinpocétine (French)
  • Vinpocetina (Spanish)

Generic Names

  • Vinpocetine (OS: USAN, JAN)
  • AX 27255 (IS: GedeonRichter)
  • Ethyl Apovincaminate (IS)
  • RGH-4405 (IS)
  • TCV-3B (IS)
  • Vinpocetine (PH: Ph. Eur. 6, BP 2010)
  • Vinpocetinum (PH: Ph. Eur. 6)

Brand Names

  • Camiton
    Drug International, Bangladesh


  • Cavinton Forte
    Gedeon Richter, Lithuania


  • Cavinton
    Biosaúde, Portugal; Gedeon Richter, Bangladesh; Gedeon Richter, China; Gedeon Richter, Czech Republic; Gedeon Richter, Egypt; Gedeon Richter, Georgia; Gedeon Richter, Hungary; Gedeon Richter, Lithuania; Gedeon Richter, Latvia; Gedeon Richter, Poland; Gedeon Richter, Romania; Gedeon Richter, Serbia; Gedeon Richter, Russian Federation; Gedeon Richter, Singapore; Gedeon Richter, Syria; Gedeon Richter, Thailand; Gedeon Richter, Vietnam; Richter Gedeon RT, Slovakia


  • Caviton
    Opsonin, Bangladesh


  • Cereton
    General Pharma, Bangladesh


  • Cerivin
    Beximco, Bangladesh


  • Ceteron
    General Pharma, Bangladesh


  • D.C. Vin
    Pentafarma, Portugal


  • Telectol
    Obolenskoe, Russian Federation


  • Ultra-Vinca
    Tecnimede, Portugal


  • Vicebrol
    Biofarm, Poland


  • Vicog
    Marjan, Brazil


  • Vilcetin
    Bidiphar, Vietnam


  • Vimpocetin
    VIM Spectrum, Romania


  • Vincet
    Eskayef, Bangladesh


  • Vinpocetin Covex
    Covex, Hungary; Covex, Latvia


  • Vinpocetin
    Laropharm, Romania


  • Vinpocetina Covex
    Covex, Spain


  • Vinpocetina Kern
    Pharmakern, Portugal


  • Vinpocetine Covex
    Covex, Lithuania; Covex, Slovakia


  • Vinpocetine Espefa
    Espefa, Poland


  • Vinpocetine Hasco
    Hasco, Poland


  • Vinpocetine
    Biopharm, Russian Federation; Canonpharma, Russian Federation; Covex, Czech Republic; Covex, Georgia; Covex, Russian Federation; Gedeon Richter, Georgia; Shreya, Russian Federation


  • Vinpocetine-Akri
    Akrihin, Russian Federation


  • Vinpocetin-Richter
    Gedeon Richter, Czech Republic


  • Vinpocetinum
    Borisov, Georgia


  • Vinpotin
    MJ Biopharm, Myanmar


  • Vinpoton
    Polfa Grodzisk, Poland


  • Vinton
    Aristopharma, Bangladesh


  • Vipocem
    Alodial, Portugal

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 16 September 2010

Vincristine Sulfate Injection




Ingredient matches for Vincristine Sulfate Injection



Vincristine

Vincristine sulfate (a derivative of Vincristine) is reported as an ingredient of Vincristine Sulfate Injection in the following countries:


  • Australia

  • New Zealand

  • United States

International Drug Name Search

Wednesday, 15 September 2010

Acido Alendronico Doc




Acido Alendronico Doc may be available in the countries listed below.


Ingredient matches for Acido Alendronico Doc



Alendronic Acid

Alendronic Acid is reported as an ingredient of Acido Alendronico Doc in the following countries:


  • Italy

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Acido Alendronico Doc in the following countries:


  • Italy

International Drug Name Search

Tuesday, 14 September 2010

Ragex




Ragex may be available in the countries listed below.


Ingredient matches for Ragex



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ragex in the following countries:


  • Italy

International Drug Name Search

Wednesday, 8 September 2010

Apo-Ketorolac




Apo-Ketorolac may be available in the countries listed below.


Ingredient matches for Apo-Ketorolac



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Apo-Ketorolac in the following countries:


  • Canada

International Drug Name Search

Friday, 3 September 2010

Meloxicam Pharmakern




Meloxicam Pharmakern may be available in the countries listed below.


Ingredient matches for Meloxicam Pharmakern



Meloxicam

Meloxicam is reported as an ingredient of Meloxicam Pharmakern in the following countries:


  • Portugal

International Drug Name Search

Sunday, 22 August 2010

Tegibs




Tegibs may be available in the countries listed below.


Ingredient matches for Tegibs



Tegaserod

Tegaserod maleate (a derivative of Tegaserod) is reported as an ingredient of Tegibs in the following countries:


  • India

International Drug Name Search

Thursday, 19 August 2010

Lansoprazol Spirig




Lansoprazol Spirig may be available in the countries listed below.


Ingredient matches for Lansoprazol Spirig



Lansoprazole

Lansoprazole is reported as an ingredient of Lansoprazol Spirig in the following countries:


  • Switzerland

International Drug Name Search

Wednesday, 18 August 2010

Carbinoxamine




In the US, Carbinoxamine (carbinoxamine systemic) is a member of the drug class antihistamines and is used to treat Allergic Reactions, Allergic Urticaria, Conjunctivitis - Allergic, Dermatographism, Hay Fever and Vasomotor Rhinitis.

US matches:

  • Carbinoxamine Maleate

  • Carbinoxamine Maleate Extended-Release Capsules

  • Carbinoxamine Maleate Liquid

  • Carbinoxamine Maleate/Tannate

  • Carbinoxamine/Dextromethorphan/Phenylephrine Drops

  • Carbinoxamine/Dextromethorphan/Phenylephrine Syrup

  • Carbinoxamine/Dextromethorphan/Pseudoephedrine Drops

  • Carbinoxamine/Dextromethorphan/Pseudoephedrine Liquid

  • Carbinoxamine/Dextromethorphan/Pseudoephedrine Suspension

  • Carbinoxamine/Hydrocodone/Phenylephrine Liquid

  • Carbinoxamine/Hydrocodone/Pseudoephedrine Liquid

  • Carbinoxamine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets

  • Carbinoxamine/Methscopolamine/Pseudoephedrine Syrup

  • Carbinoxamine/Phenylephrine Drops

  • Carbinoxamine/Phenylephrine Sustained-Release Tablets

  • Carbinoxamine/Pseudoephedrine

  • Carbinoxamine/Pseudoephedrine Controlled-Release Tablets

  • Carbinoxamine/Pseudoephedrine Drops

  • Carbinoxamine/Pseudoephedrine Liquid

  • Carbinoxamine/Pseudoephedrine Suspension

  • Carbinoxamine PD

  • Carbinoxamine

  • Carbinoxamine and pseudoephedrine

  • Carbinoxamine y pseudoephedrine

  • Carbinoxamine, dextromethorphan, and phenylephrine

  • Carbinoxamine, dextromethorphan, and pseudoephedrine

  • Carbinoxamine, dextromethorphan, y pseudoephedrine

  • Carbinoxamine, hydrocodone, and phenylephrine

  • Carbinoxamine, hydrocodone, and pseudoephedrine

  • Carbinoxamine, methscopolamine, and pseudoephedrine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R06AA08

CAS registry number (Chemical Abstracts Service)

0000486-16-8

Chemical Formula

C16-H19-Cl-N2-O

Molecular Weight

290

Therapeutic Categories

Antiallergic agent

Histamine, H₁-receptor antagonist

Chemical Name

Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-

Foreign Names

  • Carbinoxaminum (Latin)
  • Carbinoxamin (German)
  • Carbinoxamine (French)
  • Carbinoxamina (Spanish)

Generic Names

  • Carbinoxamine (OS: BAN, DCF)
  • E 112C (IS)
  • Carbinoxamine Maleate (OS: BANM, JAN)
  • Carbinoxamini maleas (IS)
  • Carbinoxamine Maleate (PH: USP 32)

Brand Names

  • Allergefon
    SERP, Burkina Faso; SERP, Benin; SERP, Central African Republic; SERP, Congo; SERP, Cote D'ivoire; SERP, Cameroon; SERP, Gabon; SERP, Guinea; SERP, Monaco; SERP, Madagascar; SERP, Mali; SERP, Mauritania; SERP, Mauritius; SERP, Niger; SERP, Senegal; SERP, Chad; SERP, Togo; SERP, Zaire


  • Became (Carbinoxamine and Pseudoephedrine)
    Yung Shin, Singapore


  • Carbinoxamine Maleate
    Boca, United States; Mikart, United States


  • Kenantist (Carbinoxamine and Triamcinolone)
    Bristol-Myers Squibb, Indonesia


  • Omega
    Omega, Argentina


  • Palgic
    Pamlab, United States


  • Rhinomode (Carbinoxamine and Phenylephrine)
    MPI, Oman


  • Rinomax (Carbinoxamine and Pseudoephedrine)
    Ern, Spain


  • Upvena
    Siu Guan, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 15 August 2010

Rheumatac




Rheumatac may be available in the countries listed below.


UK matches:

  • Rheumatac Retard 75 (SPC)

Ingredient matches for Rheumatac



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Rheumatac in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 13 August 2010

Combar




Combar may be available in the countries listed below.


Ingredient matches for Combar



Mirtazapine

Mirtazapine is reported as an ingredient of Combar in the following countries:


  • Denmark

International Drug Name Search

Monday, 9 August 2010

Digreen




Digreen may be available in the countries listed below.


Ingredient matches for Digreen



Gliclazide

Gliclazide is reported as an ingredient of Digreen in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, 4 August 2010

Octotiamine




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000137-86-0

Chemical Formula

C23-H36-N4-O5-S3

Molecular Weight

544

Therapeutic Category

Vitamin B₁

Chemical Name

Octanoic acid, 6-(acetylthio)-8-[[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-(2-hydroxyethyl)-1-propenyl]dithio]-, methyl ester

Foreign Names

  • Octotiaminum (Latin)
  • Octotiamin (German)
  • Octotiamine (French)
  • Octotiamina (Spanish)

Generic Names

  • Octotiamine (OS: JAN)
  • TATD (IS)

Brand Names

  • Neuvita
    Astellas, Japan; I'rom SeiyakuAiromu, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Broncoclar




Broncoclar may be available in the countries listed below.


Ingredient matches for Broncoclar



Carbocisteine

Carbocisteine is reported as an ingredient of Broncoclar in the following countries:


  • France

International Drug Name Search

Sunday, 25 July 2010

Clorfenamina Maleato L.CH.




Clorfenamina Maleato L.CH. may be available in the countries listed below.


Ingredient matches for Clorfenamina Maleato L.CH.



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Clorfenamina Maleato L.CH. in the following countries:


  • Chile

International Drug Name Search

Tuesday, 13 July 2010

Doxivet




Doxivet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Doxivet



Doxycycline

Doxycycline hydrochloride (a derivative of Doxycycline) is reported as an ingredient of Doxivet in the following countries:


  • Italy

International Drug Name Search

Tuesday, 6 July 2010

Vomet




Vomet may be available in the countries listed below.


Ingredient matches for Vomet



Trimethobenzamide

Trimethobenzamide hydrochloride (a derivative of Trimethobenzamide) is reported as an ingredient of Vomet in the following countries:


  • Turkey

International Drug Name Search

Monday, 5 July 2010

Mononitrat Verla




Mononitrat Verla may be available in the countries listed below.


Ingredient matches for Mononitrat Verla



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Mononitrat Verla in the following countries:


  • Germany

International Drug Name Search

Sunday, 4 July 2010

Ceparidin




Ceparidin may be available in the countries listed below.


Ingredient matches for Ceparidin



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Ceparidin in the following countries:


  • Spain

International Drug Name Search

Thursday, 1 July 2010

OsmoPrep




In the US, OsmoPrep (sodium biphosphate/sodium phosphate systemic) is a member of the drug class laxatives and is used to treat Bowel Preparation and Constipation.

US matches:

  • OsmoPrep

Ingredient matches for OsmoPrep



Sodium Phosphate

Sodium Phosphate Dibasic (a derivative of Sodium Phosphate) is reported as an ingredient of OsmoPrep in the following countries:


  • United States

Sodium Phosphate Monobasic (a derivative of Sodium Phosphate) is reported as an ingredient of OsmoPrep in the following countries:


  • United States

International Drug Name Search

Sunday, 27 June 2010

Adco-Contromet




Adco-Contromet may be available in the countries listed below.


Ingredient matches for Adco-Contromet



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Adco-Contromet in the following countries:


  • South Africa

International Drug Name Search

Thursday, 24 June 2010

Genmisin




Genmisin may be available in the countries listed below.


Ingredient matches for Genmisin



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Genmisin in the following countries:


  • Turkey

International Drug Name Search

Monday, 21 June 2010

Lamo TAD




Lamo TAD may be available in the countries listed below.


Ingredient matches for Lamo TAD



Lamotrigine

Lamotrigine is reported as an ingredient of Lamo TAD in the following countries:


  • Germany

International Drug Name Search

Peragal




Peragal may be available in the countries listed below.


Ingredient matches for Peragal



Perazine

Perazine is reported as an ingredient of Peragal in the following countries:


  • Poland

International Drug Name Search

Thursday, 10 June 2010

Immunoglobulin Deficiency Medications


There are currently no drugs listed for "Immunoglobulin Deficiency". See Immunodeficiency.





Drug List:

Wednesday, 9 June 2010

Seis-B




Seis-B may be available in the countries listed below.


Ingredient matches for Seis-B



Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Seis-B in the following countries:


  • Brazil

International Drug Name Search

Amocal




Amocal may be available in the countries listed below.


Ingredient matches for Amocal



Amlodipine

Amlodipine is reported as an ingredient of Amocal in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 7 June 2010

Tamoxistad




Tamoxistad may be available in the countries listed below.


Ingredient matches for Tamoxistad



Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxistad in the following countries:


  • Germany

International Drug Name Search

Saturday, 5 June 2010

Farlidone




Farlidone may be available in the countries listed below.


Ingredient matches for Farlidone



Budesonide

Budesonide is reported as an ingredient of Farlidone in the following countries:


  • Greece

International Drug Name Search

Thursday, 3 June 2010

Glimepirid Stada




Glimepirid STADA may be available in the countries listed below.


Ingredient matches for Glimepirid STADA



Glimepiride

Glimepiride is reported as an ingredient of Glimepirid STADA in the following countries:


  • Austria

  • Denmark

  • Germany

  • Sweden

International Drug Name Search

Hetailin




Hetailin may be available in the countries listed below.


Ingredient matches for Hetailin



Aprotinin

Aprotinin is reported as an ingredient of Hetailin in the following countries:


  • China

International Drug Name Search

Tuesday, 1 June 2010

C-Vit




C-Vit may be available in the countries listed below.


Ingredient matches for C-Vit



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of C-Vit in the following countries:


  • Austria

International Drug Name Search

Thursday, 27 May 2010

Captowa




Captowa may be available in the countries listed below.


Ingredient matches for Captowa



Captopril

Captopril is reported as an ingredient of Captowa in the following countries:


  • Japan

International Drug Name Search

Monday, 24 May 2010

Valdure




Valdure may be available in the countries listed below.


Ingredient matches for Valdure



Parecoxib

Parecoxib sodium salt (a derivative of Parecoxib) is reported as an ingredient of Valdure in the following countries:


  • Belize

  • Costa Rica

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Sunday, 23 May 2010

Ezon-T




Ezon-T may be available in the countries listed below.


Ingredient matches for Ezon-T



Tolnaftate

Tolnaftate is reported as an ingredient of Ezon-T in the following countries:


  • Myanmar

International Drug Name Search

Monday, 17 May 2010

Vasomotal




Vasomotal may be available in the countries listed below.


Ingredient matches for Vasomotal



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Vasomotal in the following countries:


  • Germany

International Drug Name Search

Vonafec




Vonafec may be available in the countries listed below.


Ingredient matches for Vonafec



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Vonafec in the following countries:


  • Japan

International Drug Name Search

Sunday, 9 May 2010

Rebif


Generic Name: interferon beta-1a (Intramuscular route, Subcutaneous route)


in-ter-FEER-on BAY-ta-1a


Commonly used brand name(s)

In the U.S.


  • Avonex

  • Rebif

Available Dosage Forms:


  • Solution

  • Kit

Therapeutic Class: Immunological Agent


Pharmacologic Class: Interferon, Beta (class)


Uses For Rebif


Interferon beta-1a injection is used to treat the relapsing forms of multiple sclerosis (MS). This medicine will not cure MS, but it may slow some disabling effects and decrease the number of relapses of the disease. Interferons are natural substances that are produced in the body to help fight infections. Interferon beta-1a is a synthetic (man-made) version of these substances.


This medicine is available only with your doctor's prescription.


Before Using Rebif


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of interferon beta-1a injection in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of interferon beta-1a injection in the elderly. However, elderly patients are more likely to have age-related liver problems, which may require caution in patients receiving interferon beta-1a injection.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Zidovudine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Angina (severe chest pain) or

  • Autoimmune disorders (e.g., autoimmune hepatitis, idiopathic thrombocytopenia) or

  • Bone marrow problems (decreased amounts of red or white blood cells in your body), history of or

  • Congestive heart failure or

  • Depression or mental problems, history of or

  • Heart disease (e.g., cardiomyopathy) or

  • Heart rhythm problems (e.g., arrhythmia) or

  • Liver disease or

  • Seizures or epilepsy, history of or

  • Thyroid problems—Use with caution. May make these conditions worse.

  • Infection—May decrease your body's ability to fight infection.

Proper Use of interferon beta-1a

This section provides information on the proper use of a number of products that contain interferon beta-1a. It may not be specific to Rebif. Please read with care.


A nurse or other trained health professional will give you this medicine. You may also be taught how to give your medicine at home. This medicine is given as a shot under your skin or into a muscle.


If you are injecting interferon beta-1a yourself, use it exactly as directed by your doctor. Do not use more or less of it, and do not use it more often than your doctor ordered. Do not change your dose or dosing schedule without checking first with your doctor. The exact amount of medicine you need has been carefully worked out. Using too much will increase the risk of side effects, while using too little may not improve your condition.


You will be shown the body areas where this shot can be given. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas.


Use only the brand of this medicine that your doctor prescribed. Different brands may not work the same way.


Rebif® works best if you use it on the same time (usually in the late afternoon or evening) on the same three days (e.g., Monday, Wednesday, and Friday) at least 48 hours apart each week.


Avonex® comes as a prefilled syringe or a powder. The powder must be mixed with sterile water before it is given. Do not shake the vial after you add the water. Gently swirl the water and medicine together to mix. The mixture should be clear or slightly yellow. Do not use the mixture if you see particles in it. Use the medicine as soon as possible after mixing. If you cannot give your shot right away, you can keep the syringe in the refrigerator for up to 6 hours. After 6 hours, throw the medicine away and mix another dose.


Use a new needle, unopened vial, or syringe each time you inject your medicine.


Each package of interferon beta-1a injection contains a medication guide and patient instruction sheet. Read this sheet carefully and make sure you understand:


  • How to prepare the injection.

  • Proper use of disposable syringes.

  • How to give the injection.

  • How long the injection is stable.

If you have any questions about any of this, check with your doctor.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For multiple sclerosis (MS):
      • Adults—
        • For Avonex®:
          • 30 micrograms (mcg) injected into a muscle once a week, on the same day (e.g., every Monday right before bedtime). Your doctor may choose a different dose (more or less) if necessary.


        • For Rebif®:
          • At first, 4.4 or 8.8 micrograms (mcg) injected under the skin three times a week. Your doctor will increase or decrease your dose until you reach the correct amount for you.



      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


If you miss a dose or forget to use your medicine, use it as soon as you can. This will then change the time for your next dose. After using the missed dose, use your next regular dose of Rebif® 48 hours later and go back to your regular schedule the following week. For Avonex®, if your next regular dose is less than 2 days away, call your doctor. For either brand, do not use extra medicine to make up for a missed dose and do not use this medicine two days in a row.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store prefilled syringes or vials in the refrigerator. Do not freeze. If refrigeration is not available, Rebif® prefilled syringes and Avonex® powder vials may be kept for up to 30 days at room temperature, away from heat (temperatures above 77 degrees F) and direct light. Avonex® prefilled syringes may be stored for up to 7 days at room temperature, away from heat (temperatures above 77 degrees F) and direct light. Allow Avonex® prefilled syringes to warm to room temperature (remove from the refrigerator for about 30 minutes) before injection but do not heat in a microwave oven or in hot water.


Throw the used needles away in a hard, closed container that the needles cannot poke through. Keep this container away from children and pets.


Precautions While Using Rebif


It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.


Using this medicine while you are pregnant may cause you to lose your baby or can harm your unborn baby. Tell your doctor right away if you think you are pregnant or if you plan to become pregnant while using this medicine. Also, tell your doctor if you are breastfeeding.


This medicine may cause some people to be anxious, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed. If you or your caregiver notice any of these side effects, tell your doctor right away.


Check with your doctor right away if you have dark urine, persistent loss of appetite, influenza (flu)-like symptoms, headache, continuing vomiting, general feeling of tiredness or weakness, light-colored stools, right upper stomach pain or tenderness, or yellow eyes or skin. These could be symptoms of a serious liver problem.


You should avoid alcohol while you are taking this medicine. It can cause serious liver problems.


This medicine may cause serious allergic reactions including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash; itching; hoarseness; trouble breathing; trouble swallowing; or any swelling of your hands, face, or mouth while you are using this medicine.


This medicine may lower the number of white blood cells in the blood. This will increase your chance of getting an infection. It can also lower the number of platelets in the blood. Platelets are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects, such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

This medicine may cause redness, pain, or swelling at the injection site. Some patients have developed skin infections or a permanent depression (necrosis) under the skin at the injection site. Contact your doctor right away if you notice any of these side effects at the injection site: depressed or indented skin; blue-green to black skin discoloration; or pain, redness, or sloughing (peeling) of the skin.


This medicine commonly causes a flu-like reaction, with aching muscles, chills, fever, headache, joint pain, and nausea. Using your shot at bedtime may allow you to sleep through the symptoms. Your doctor may want you to take a medicine for pain and fever (e.g., acetaminophen or ibuprofen) to help control these effects. Follow your doctor's instructions carefully about how to prevent or treat these symptoms.


This medicine contains albumin, which comes from human blood. Some human blood products have transmitted certain viruses to people who have received them. The risk of getting a virus from medicines made of human blood has been greatly reduced in recent years. This is the result of required testing of human donors for certain viruses, and testing during manufacture of these medicines. Although the risk is low, talk with your doctor if you have concerns. The Avonex® prefilled syringe does not contain albumin which comes from donated human blood.


Rebif Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Black, tarry stools

  • chest pain

  • chills

  • cough

  • diarrhea

  • fever

  • flu-like symptoms

  • headache

  • joint pain

  • muscle aches

  • nausea

  • pain

  • painful or difficult urination

  • shortness of breath

  • sores, ulcers, or white spots on the lips or in the mouth

  • swollen glands

  • unusual bleeding or bruising

  • unusual tiredness or weakness

Less common
  • Abdominal or stomach pain

  • clumsiness or unsteadiness

  • convulsions (seizures)

  • decreased hearing

  • difficulty with swallowing

  • dizziness

  • fainting

  • feeling of warmth

  • hives or itching

  • mood changes, especially with thoughts of suicide

  • muscle spasms

  • pain or discharge from the vagina

  • pelvic discomfort, aching, or heaviness

  • redness of the face, neck, arms, and occasionally, upper chest

  • redness, swelling, or tenderness at the injection site

  • runny or stuffy nose

  • skin lesions

  • sneezing

  • sore throat

  • speech problems

  • swelling of the face, lips, or eyelids

  • troubled breathing

  • wheezing

Rare
  • Earache

  • general feeling of discomfort or illness

  • loss of appetite

  • painful blisters on trunk of body

  • painful cold sores or blisters on the lips, nose, eyes, or genitals

Incidence not known
  • Bleeding gums

  • blood in the urine or stools

  • bloody nose

  • chest discomfort

  • confusion

  • constipation

  • continuing vomiting

  • dark urine

  • decreased urine output

  • depressed mood

  • dilated neck veins

  • dry skin and hair

  • extreme fatigue

  • fast, irregular, or pounding heartbeat

  • feeling cold

  • general tiredness and weakness

  • hair loss

  • heavier menstrual periods

  • high fever

  • hoarseness or husky voice

  • irregular breathing

  • light-colored stools

  • loss of bladder control

  • mental depression

  • mood or other mental changes

  • muscle cramps and stiffness

  • muscle spasm or jerking of all extremities

  • nausea or vomiting

  • nervousness

  • pale skin

  • persistent loss of appetite

  • pinpoint red spots on the skin

  • puffiness or swelling of the eyelids, or around the eyes, face, lips, or tongue

  • redness, blistering, peeling, or loosening of the skin

  • sensitivity to heat

  • skin rash

  • slowed heartbeat

  • sudden loss of consciousness

  • sweating

  • swelling of the face, fingers, feet, or lower legs

  • swelling of the mouth or throat

  • tightness in the chest

  • tightness in the throat

  • upper right abdominal or stomach pain or tenderness

  • weight gain or loss

  • yellow eyes and skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Heartburn

  • indigestion

  • sour stomach

Less common
  • Hair loss

  • trouble with sleeping

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Rebif side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Rebif resources


  • Rebif Side Effects (in more detail)
  • Rebif Use in Pregnancy & Breastfeeding
  • Rebif Drug Interactions
  • Rebif Support Group
  • 10 Reviews for Rebif - Add your own review/rating


  • Rebif Prescribing Information (FDA)

  • Rebif MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rebif Consumer Overview

  • Interferon Beta-1a Professional Patient Advice (Wolters Kluwer)

  • Avonex Consumer Overview

  • Avonex Prescribing Information (FDA)

  • Avonex Prefilled Syringes MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Rebif with other medications


  • Multiple Sclerosis
  • Neuritis